{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T21:06:16Z","timestamp":1770757576359,"version":"3.50.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.numecd.2025.104459","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:12:16Z","timestamp":1762902736000},"page":"104459","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Uric-acid predictive performance analysis for subclinical organ damage in essential hypertensive patients"],"prefix":"10.1016","volume":"36","author":[{"given":"Luigi","family":"Petramala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gioacchino","family":"Galardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Circosta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Servello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7380-6222","authenticated-orcid":false,"given":"Luca","family":"Marino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Caprioni Grasso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Baratta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Renna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giancarlo","family":"Ceccarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Moscucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Nardoianni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuliano","family":"Tocci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovambattista","family":"Desideri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Letizia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2025.104459_bib1","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra0800885","article-title":"Uric acid and cardiovascular risk","volume":"359","author":"Feig","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2025.104459_bib2","doi-asserted-by":"crossref","DOI":"10.1186\/s12944-025-02440-w","article-title":"Predictive value of TG\/HDL-C and GFR-adjusted uric acid levels on cardiovascular mortality: the URRAH study","author":"Russo","year":"2025","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.numecd.2025.104459_bib3","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/s41371-021-00613-5","article-title":"Identification of a plausible serum uric acid cut-off value as prognostic marker of stroke: the uric acid right for heart health (URRAH) study","volume":"36","author":"Tikhonoff","year":"2022","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.numecd.2025.104459_bib4","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1016\/j.numecd.2024.09.012","article-title":"Uric acid and risk of incident heart failure in individuals with cardiovascular disease","volume":"34","author":"Li","year":"2024","journal-title":"Nutr Metabol Cardiovasc Dis"},{"key":"10.1016\/j.numecd.2025.104459_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2020.582680","article-title":"Uric acid and cardiovascular disease: an update from molecular mechanism to clinical perspective","volume":"11","author":"Yu","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.numecd.2025.104459_bib6","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1016\/j.numecd.2024.05.023","article-title":"Serum uric acid, body mass index, and cardiovascular diseases: a multiple two-step Mendelian randomization study","volume":"34","author":"Chen","year":"2024","journal-title":"Nutr Metabol Cardiovasc Dis"},{"key":"10.1016\/j.numecd.2025.104459_bib7","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1053\/j.ajkd.2017.12.009","article-title":"Hyperuricemia, acute and chronic kidney disease, hypertension, and cardiovascular disease: report of a scientific workshop organized by the national kidney foundation","volume":"71","author":"Johnson","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.numecd.2025.104459_bib8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s40292-020-00368-z","article-title":"Hyperuricemia and risk of cardiovascular outcomes: the experience of the URRAH (Uric acid right for heart health) project","volume":"27","author":"Maloberti","year":"2020","journal-title":"High Blood Pres Cardiovasc Prev"},{"key":"10.1016\/j.numecd.2025.104459_bib9","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s40292-023-00602-4","article-title":"The results of the URRAH (Uric acid right for heart health) project: a focus on hyperuricemia in relation to cardiovascular and kidney disease and its role in metabolic dysregulation","volume":"30","author":"Maloberti","year":"2023","journal-title":"High Blood Pres Cardiovasc Prev"},{"key":"10.1016\/j.numecd.2025.104459_bib10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s40292-018-0250-7","article-title":"Exploration into uric and cardiovascular disease: uric acid right for heArt health (URRAH) project, A study protocol for a retrospective observational study","volume":"25","author":"Desideri","year":"2018","journal-title":"High Blood Pres Cardiovasc Prev"},{"key":"10.1016\/j.numecd.2025.104459_bib11","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1161\/HYPERTENSIONAHA.119.13643","article-title":"Identification of the uric acid thresholds predicting an increased total and cardiovascular mortality over 20 years","volume":"75","author":"Virdis","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.numecd.2025.104459_bib12","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/HJH.0000000000003068","article-title":"The association of uric acid with mortality modifies at old age: data from the uric acid right for heart health (URRAH) study","volume":"40","author":"Ungar","year":"2022","journal-title":"J Hypertens"},{"key":"10.1016\/j.numecd.2025.104459_bib13","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.numecd.2022.01.028","article-title":"Serum uric acid levels threshold for mortality in diabetic individuals: the URic acid right for heArt health (URRAH) project","volume":"32","author":"Masulli","year":"2022","journal-title":"Nutr Metabol Cardiovasc Dis"},{"key":"10.1016\/j.numecd.2025.104459_bib14","article-title":"Serum uric acid, hypertriglyceridemia, and carotid plaques: a sub-analysis of the URic acid right for","author":"Agabiti Rosei","year":"2024","journal-title":"Heart Health (URRAH) Study Metabolites"},{"key":"10.1016\/j.numecd.2025.104459_bib15","first-page":"1","article-title":"Serum uric acid predicts all-cause and cardiovascular mortality independently of hypertriglyceridemia in cardiometabolic patients without established CV disease: a sub-analysis of the URic acid right for","volume":"13","author":"Mengozzi","year":"2023","journal-title":"heArt Health (URRAH) Study Metabolites"},{"key":"10.1016\/j.numecd.2025.104459_bib16","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/HJH.0000000000003319","article-title":"Serum uric acid\/serum creatinine ratio as a predictor of cardiovascular events. Detection of prognostic cardiovascular cut-off values","volume":"41","author":"Casiglia","year":"2023","journal-title":"J Hypertens"},{"key":"10.1016\/j.numecd.2025.104459_bib17","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","article-title":"2023 ESH guidelines for the management of arterial hypertension the task force for the management of arterial hypertension of the european society of hypertension","volume":"41","author":"Mancia","year":"2023","journal-title":"J Hypertens"},{"key":"10.1016\/j.numecd.2025.104459_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcvm.2024.1369090","article-title":"Relevance of obesity-related organ damage and metabolic syndrome classification in cardiovascular and renal risk stratification in patients with essential hypertension","volume":"11","author":"Petramala","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.numecd.2025.104459_bib19","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/ehjci\/jew082","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American society of echocardiography and the european association of cardiovascular imaging","volume":"17","author":"Nagueh","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.numecd.2025.104459_bib20","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1161\/01.HYP.0000161184.10873.ea","article-title":"Serum uric acid and target organ damage in primary hypertension","volume":"45","author":"Viazzi","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.numecd.2025.104459_bib21","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1365-2796.2005.01468.x","article-title":"Metabolic syndrome is associated with early signs of organ damage in nondiabetic, hypertensive patients","volume":"257","author":"Leoncini","year":"2005","journal-title":"J Intern Med"},{"key":"10.1016\/j.numecd.2025.104459_bib22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejim.2023.04.006","article-title":"Xanthine oxidase inhibition and cardiovascular protection: don't shoot in the dark","volume":"113","author":"Desideri","year":"2023","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.numecd.2025.104459_bib23","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1161\/HYPERTENSIONAHA.115.06531","article-title":"Urate-lowering drugs and prevention of cardiovascular disease: the emerging role of xanthine oxidase inhibition","volume":"67","author":"Borghi","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.numecd.2025.104459_bib24","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.numecd.2016.03.011","article-title":"Serum uric acid level and left ventricular hypertrophy in elderly male patients with nonvalvular atrial fibrillation","volume":"26","author":"Liang","year":"2016","journal-title":"Nutr Metabol Cardiovasc Dis"},{"key":"10.1016\/j.numecd.2025.104459_bib25","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejim.2023.04.010","article-title":"Serum uric acid and left ventricular mass index independently predict cardiovascular mortality: the uric acid right for heart health (URRAH) project","volume":"114","author":"Muiesan","year":"2023","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.numecd.2025.104459_bib26","first-page":"1295","article-title":"Is it time to revise the normal range of serum uric acid levels?","volume":"18","author":"Desideri","year":"2014","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.numecd.2025.104459_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.numecd.2024.103796","article-title":"Hyperuricemia, A new cardiovascular risk","volume":"35","author":"Kuwabara","year":"2025","journal-title":"Nutr Metabol Cardiovasc Dis"},{"key":"10.1016\/j.numecd.2025.104459_bib28","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1136\/heartjnl-2014-305683","article-title":"Allopurinol reduces brachial and central blood pressure, and carotid intima-media thickness progression after ischaemic stroke and transient ischaemic attack: a randomised controlled trial","volume":"100","author":"Higgins","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.numecd.2025.104459_bib29","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(22)01786-X","article-title":"Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial","volume":"400","author":"Mackenzie","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.numecd.2025.104459_bib30","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1161\/CIRCULATIONAHA.114.014536","article-title":"Effects of xanthine oxidase inhibition in hyperuricemic heart failure patients: the xanthine oxidase inhibition for hyperuricemic heart failure patients (EXACT-HF) study","volume":"131","author":"Givertz","year":"2015","journal-title":"Circulation"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475325006143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475325006143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:39:27Z","timestamp":1770741567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475325006143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0939475325006143"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2025.104459","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uric-acid predictive performance analysis for subclinical organ damage in essential hypertensive patients","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2025.104459","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104459"}}